Literature DB >> 1510412

In vivo antibiotic synergism: contribution of animal models.

B Fantin1, C Carbon.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1510412      PMCID： PMC188745          DOI： 10.1128/AAC.36.5.907

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  56 in total

1.  Antimicrobial therapy of experimental intraabdominal sepsis.

Authors:  W M Weinstein; A B Onderdonk; J G Bartlett; T J Louie; S L Gorbach
Journal:  J Infect Dis       Date:  1975-09       Impact factor: 5.226

2.  Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes.

Authors:  W M Scheld; D D Fletcher; F N Fink; M A Sande
Journal:  J Infect Dis       Date:  1979-09       Impact factor: 5.226

3.  Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats.

Authors:  R E Scott; H G Robson
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

4.  Therapy of neutropenic rats infected with Pseudomonas aeruginosa.

Authors:  R M Lumish; C W Norden
Journal:  J Infect Dis       Date:  1976-05       Impact factor: 5.226

5.  Synergism of ampicillin and gentamicin against obstructive pyelonephritis due to Escherichia coli in rats.

Authors:  M P Glauser; J M Lyons; A I Braude
Journal:  J Infect Dis       Date:  1979-02       Impact factor: 5.226

6.  Synergy between ticarcillin and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae in vitro and in vivo.

Authors:  K R Comber; M J Basker; C D Osborne; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

7.  Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium.

Authors:  F Caron; C Carbon; L Gutmann
Journal:  J Infect Dis       Date:  1991-11       Impact factor: 5.226

8.  Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.

Authors:  M A Sande; K B Courtney
Journal:  J Lab Clin Med       Date:  1976-07

9.  Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis.

Authors:  M Michéa-Hamzehpour; R Auckenthaler; P Regamey; J C Pechère
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

10.  Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium.

Authors:  B Fantin; R Leclercq; M Arthur; J Duval; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191
View more
  38 in total

Review 1.  Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis.

Authors:  A C Cremieux; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

2.  In vitro and in vivo interactions between miltefosine and other antileishmanial drugs.

Authors:  Karin Seifert; Simon L Croft
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  The population dynamics of antimicrobial chemotherapy.

Authors:  M Lipsitch; B R Levin
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

4.  Importance of penicillinase production for activity of penicillin alone or in combination with sulbactam in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Authors:  B Fantin; J Pierre; N Castéla-Papin; L Saint-Julien; H Drugeon; R Farinotti; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

Review 5.  Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.

Authors:  Tiphaine Goulenok; Bruno Fantin
Journal:  Clin Pharmacokinet       Date:  2013-10       Impact factor: 6.447

6.  Combination therapy with tamoxifen and amphotericin B in experimental cutaneous leishmaniasis.

Authors:  Cristiana T Trinconi; Juliana Q Reimão; Jenicer K U Yokoyama-Yasunaka; Danilo C Miguel; Silvia R B Uliana
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

7.  Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Authors:  Fu-Yu Chiang; Michael Climo
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

8.  In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis.

Authors:  B Fantin; R Leclercq; M Ottaviani; J M Vallois; B Maziere; J Duval; J J Pocidalo; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

9.  Bactericidal activity of the combination of levofloxacin with rifampin in experimental prosthetic knee infection in rabbits due to methicillin-susceptible Staphylococcus aureus.

Authors:  Claudette Muller-Serieys; Azzam Saleh Mghir; Laurent Massias; Bruno Fantin
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

10.  Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.

Authors:  I R Friedland; M Paris; S Ehrett; S Hickey; K Olsen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.